AdBoard
BioProNeo BV is proud to introduce our knowledgable Advisory Board.
Irwin Reiss
Professor Neonatology, Erasmus MC, Rotterdam
BioProNeo
Sinno Simons
Neonatologist - clinical pharmacologist, Erasmus UMC Sophia‘s Children’s Hospital, Rotterdam
Next to his work as a consultant neonatologist, Sinno Simons is the principle investigator of several pharmacological clinical trials in newborn infants. His focus is on the improvement of current neonatal pharmacotherapy and the development of new interventions to improve neonatal outcome. In extension to that his research focus is also on the development of new treatment strategies to improve outcome by foetal pharmacological therapy. He currently is the pharmacology section secretary of the European Society for Pediatric Research.
Bart van den Bemt
Professor in Personalized Pharmaceutical Care, UMC St Radboud, Nijmegen
BioProNeo
Karel Allegaert
Associate Professor KU Leuven, Belgium
Prof dr Karel Allegaert, is pediatrician-neonatologist and clinical pharmacologist. He is associate Professor (Department of Development and Regeneration, and Pharmaceutical and Pharmacological Sciences KU Leuven) and consultant (Department of Clinical Pharmacy) Erasmus MC Rotterdam. His clinical research is focussed on perinatal and neonatal clinical pharmacology and the relevant co-variates (maturational, non-maturational, pharmacogenetics, disease-related, pregnancy related), and the subsequent use of in vivo datasets to develop prediction models. More recently, his research further expanded to in vitro models (placenta, renal tubular cells), in vivo models (bronchopulmonary dysplasia rabbit) and long term pharmacovigilance in former preterm neonates.
Sources
https://orcid.org/0000-0001-9921-5105, https://www.researchgate.net/profile/Karel_Allegaert.